Document Detail


Treatment with DNAse I fosters binding to nec PBMC of CRP.
MedLine Citation:
PMID:  19811278     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CRP is an important inflammatory marker, however, CRP levels are relatively low in patients with SLE. In addition patients with SLE often display low activities and serum levels for DNase I and complement, respectively. Here we show that DNase I treatment of nec PBMC increased their binding of CRP. Consequently, reduced DNase I activity in patients with SLE may contribute to the impaired opsonisation by CRP of dead cells, exacerbating the clearance defect in SLE of apo and nec cells.
Authors:
Christina Janko; Christine Schorn; Daniela Weidner; Kerstin Sarter; Ricardo Chaurio; Ahmed Sheriff; Georg Schett; Luis E Munoz
Related Documents :
20190028 - Effect of oral n-acetylcysteine treatment on plasma inflammatory and oxidative stress m...
10380568 - Serum cytokines in chronic chagas' disease.
14526428 - Relationship between levels of serum c-reactive protein, leucocyte count and carotid pl...
19787418 - Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for m...
7634548 - Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients ...
10436298 - Sickle-cell disease in brazzaville, congo: genetical, hematological, biochemical and cl...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Autoimmunity     Volume:  42     ISSN:  1607-842X     ISO Abbreviation:  Autoimmunity     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-10-08     Completed Date:  2009-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8900070     Medline TA:  Autoimmunity     Country:  England    
Other Details:
Languages:  eng     Pagination:  286-8     Citation Subset:  IM    
Affiliation:
Department for Internal Medicine 3, Institute for Clinical Immunology, Friedrich-Alexander University of Erlangen-N??rnberg, Erlangen, Germany. christina.janko@uk-erlangen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
C-Reactive Protein / metabolism*
Cells, Cultured
Deoxyribonuclease I / immunology,  metabolism*
Flow Cytometry
Humans
Leukocytes, Mononuclear / immunology,  metabolism*,  pathology*
Necrosis
Phagocytosis / immunology
Chemical
Reg. No./Substance:
9007-41-4/C-Reactive Protein; EC 3.1.21.1/Deoxyribonuclease I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  C-reactive protein in systemic lupus erythematosus.
Next Document:  oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.